ViAqua Therapeutics Overview

  • Founded
  • 2014
Founded
  • Status
  • Private
  • Latest Deal Type
  • Early Stage VC
  • Investors
  • 5

ViAqua Therapeutics General Information

Description

Developer of an orally administered particle-based platform designed to prevent diseases from developing viral epidemics in aquaculture. The company's platform utilizes a proprietary RNAi nanoparticle formulation that triggers a cellular reaction to disable the viral infection and delivers the coated nanoparticles via feed or immersion, enabling aquaculture industries to improve resistance against viral diseases that attack shrimp and other aquaculture species.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Aquaculture
Primary Office
  • Gutvirt Park, Technion city
  • Haifa 3200003
  • Israel
+972 000-000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

ViAqua Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC 12-Dec-2018 Completed Generating Revenue
2. Early Stage VC 04-Jul-2018 Completed Generating Revenue
1. Accelerator/Incubator Completed Startup
To view ViAqua Therapeutics’s complete valuation and funding history, request access »

ViAqua Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of an orally administered particle-based platform designed to prevent diseases from developing viral epidemics
Biotechnology
Haifa, Israel
0000000000 0

0000000

g elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam,
0000 000000000
Leuven, Belgium
00 As of 0000
000.00
00.00 0000-00-00
00000000000 000.00

0000000

dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliq
000000000000000
Nicholasville, KY
0000 As of 0000
00000
000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

ViAqua Therapeutics Competitors (3)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
ViroVet Venture Capital-Backed Leuven, Belgium 00 000.00 00000000000 000.00
0000000 Private Debt Financed Nicholasville, KY 0000 00000 000000000 00000
000000 0000000 000 Formerly PE-Backed Hanoi, Vietnam 000000000000
To view ViAqua Therapeutics’s complete competitors history, request access »

ViAqua Therapeutics Executive Team (3)

Name Title Board Seat Contact Info
Shai Ufaz Ph.D Co-Founder & Chief Executive Officer
Shai Einbinder Ph.D Co-Founder & Director
Dganit Vered Chairperson & Vice President, Business Development
To view ViAqua Therapeutics’s complete executive team members history, request access »

ViAqua Therapeutics Board Members (1)

Name Representing Role Since
Dganit Vered Self Chairperson & Vice President, Business Development 000 0000
To view ViAqua Therapeutics’s complete board members history, request access »

ViAqua Therapeutics Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
New Protein Capital Venture Capital Minority 000 0000 000000 0
Israel Innovation Authority Government Minority 000 0000 000000 0
Nutreco Corporation Minority 000 0000 000000 0
Technion Israel Institute of Technology University Minority 000 0000 000000 0
The Trendlines Group Accelerator/Incubator Minority 000 0000 000000 0
To view ViAqua Therapeutics’s complete investors history, request access »